These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 35012539)

  • 21. ELF1 activated long non-coding RNA CASC2 inhibits cisplatin resistance of non-small cell lung cancer via the miR-18a/IRF-2 signaling pathway.
    Xiao XH; He SY
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3130-3142. PubMed ID: 32271431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. microRNA-137 promotes apoptosis in ovarian cancer cells via the regulation of XIAP.
    Li X; Chen W; Zeng W; Wan C; Duan S; Jiang S
    Br J Cancer; 2017 Jan; 116(1):66-76. PubMed ID: 27875524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-4486 reverses cisplatin-resistance of colon cancer cells via targeting ATG7 to inhibiting autophagy.
    Wang W; Chen L; Zhu W; Huang X; Lin L; Quan Z; Sun K; Xu Q
    Exp Ther Med; 2021 Dec; 22(6):1465. PubMed ID: 34737805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-375 targeting autophagy-related 2B (ATG2B) suppresses autophagy and tumorigenesis in cisplatin-resistant osteosarcoma cells.
    Gao S; Wang K; Wang X
    Neoplasma; 2020 Jul; 67(4):724-734. PubMed ID: 32726125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-142-5p enhances cisplatin-induced apoptosis in ovarian cancer cells by targeting multiple anti-apoptotic genes.
    Li X; Chen W; Jin Y; Xue R; Su J; Mu Z; Li J; Jiang S
    Biochem Pharmacol; 2019 Mar; 161():98-112. PubMed ID: 30639456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-186 induces sensitivity of ovarian cancer cells to paclitaxel and cisplatin by targeting ABCB1.
    Sun KX; Jiao JW; Chen S; Liu BL; Zhao Y
    J Ovarian Res; 2015 Dec; 8():80. PubMed ID: 26626440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oridonin effectively reverses cisplatin drug resistance in human ovarian cancer cells via induction of cell apoptosis and inhibition of matrix metalloproteinase expression.
    Ma S; Tan W; Du B; Liu W; Li W; Che D; Zhang G
    Mol Med Rep; 2016 Apr; 13(4):3342-8. PubMed ID: 26935490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MiR-187 influences cisplatin-resistance of gastric cancer cells through regulating the TGF-β/Smad signaling pathway.
    Zhu QL; Li Z; Lv CM; Wang W
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9907-9914. PubMed ID: 31799659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancing wound healing and overcoming cisplatin resistance in ovarian cancer.
    Zhang Q; Guo F; Liu H; Hong L
    Int Wound J; 2024 Apr; 21(4):e14569. PubMed ID: 38158767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Expression of microRNA-100 and its correlation with drug resistance in human ovarian cancer SKOV3/DDP cells].
    Guo P; Peng D; Xiong X; Zhang S
    Nan Fang Yi Ke Da Xue Xue Bao; 2015 Nov; 35(11):1624-7. PubMed ID: 26607088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MiR-34a-5p/PD-L1 axis regulates cisplatin chemoresistance of ovarian cancer cells.
    Zuo Y; Zheng W; Liu J; Tang Q; Wang SS; Yang XS
    Neoplasma; 2020 Jan; 67(1):93-101. PubMed ID: 31777260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Propofol inhibits proliferation and cisplatin resistance in ovarian cancer cells through regulating the microRNA‑374a/forkhead box O1 signaling axis.
    Sun Y; Peng YB; Ye LL; Ma LX; Zou MY; Cheng ZG
    Mol Med Rep; 2020 Mar; 21(3):1471-1480. PubMed ID: 32016462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-873 mediates multidrug resistance in ovarian cancer cells by targeting ABCB1.
    Wu DD; Li XS; Meng XN; Yan J; Zong ZH
    Tumour Biol; 2016 Aug; 37(8):10499-506. PubMed ID: 26850595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Regulatory effects and associated mechanisms of miR-130a molecules on cisplatin resistance in ovarian cancer A2780 cell lines].
    Li NW; Wang HJ; Yang LY; Jia XB; Chen C; Wang X
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Nov; 44(6):865-70. PubMed ID: 24490491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CircRNA_100565 contributes to cisplatin resistance of NSCLC cells by regulating proliferation, apoptosis and autophagy via miR-337-3p/ADAM28 axis.
    Zhong Y; Lin H; Li Q; Liu C; Shen J
    Cancer Biomark; 2021; 30(2):261-273. PubMed ID: 33682697
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oncogenic microRNA-181d binding to OGT contributes to resistance of ovarian cancer cells to cisplatin.
    Huang W; Chen L; Zhu K; Wang D
    Cell Death Discov; 2021 Dec; 7(1):379. PubMed ID: 34876558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-125a-5p targets LIM kinase 1 to inhibit cisplatin resistance of cervical cancer cells.
    Xu Y; Zheng Y; Duan Y; Ma L; Nan P
    Oncol Lett; 2021 May; 21(5):392. PubMed ID: 33777215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of miR-140-5p on the regulation of proliferation and apoptosis in NSCLC and its underlying mechanism.
    Zhou W; Wang X; Yin D; Xue L; Ma Z; Wang Z; Zhang Q; Zhao Z; Wang H; Sun Y; Yang Y
    Exp Ther Med; 2019 Aug; 18(2):1350-1356. PubMed ID: 31363375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Restoration of microRNA-708 sensitizes ovarian cancer cells to cisplatin via IGF2BP1/Akt pathway.
    Qin X; Sun L; Wang J
    Cell Biol Int; 2017 Oct; 41(10):1110-1118. PubMed ID: 28685895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MiR-17-5p up-regulates YES1 to modulate the cell cycle progression and apoptosis in ovarian cancer cell lines.
    Li L; He L; Zhao JL; Xiao J; Liu M; Li X; Tang H
    J Cell Biochem; 2015 Jun; 116(6):1050-9. PubMed ID: 25561420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.